-
Canonic Launches Its High THC Medical Cannabis Products In Israel
Wednesday, September 21, 2022 - 11:38am | 435Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN), is launching its second-generation products in Israel. The design of the new products leverages market feedback since Canonic's launch of its...
-
Medical-Grade Cannabis Developer Canonic Appoints Ex-SEO At Israeli Ministry Of Health To Its Board
Wednesday, February 16, 2022 - 8:58am | 343Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), announced that professor Itamar Grotto will be joining its board of directors. Grotto, former associate director general at the Israeli ministry of health, was responsible for the...
-
Evogene's Canonic Launches First Two Medical Cannabis Products In Israel Ahead Of Schedule
Tuesday, October 19, 2021 - 9:16am | 355Evogene Ltd.'s (NASDAQ: EVGN) (TASE: EVGN) wholly-owned subsidiary focused on developing medical cannabis products, Canonic Ltd., announced the full commercial launch of its first two medical cannabis inflorescence products, known as G200 and G150. The Israel-based company said Tuesday that the...